Gallo Partners LP bought a new position in shares of Nordson Corporation (NASDAQ:NDSN – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,393 shares of the industrial products company’s stock, valued at approximately $2,532,000. Nordson comprises about 5.6% of Gallo Partners LP’s portfolio, making the stock its 5th biggest holding.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cibc World Market Inc. bought a new position in shares of Nordson during the second quarter valued at $538,000. OMERS ADMINISTRATION Corp bought a new stake in shares of Nordson in the second quarter worth $923,000. Osmosis Investment Management UK Ltd bought a new stake in shares of Nordson in the second quarter worth $1,921,000. Sanctuary Advisors LLC acquired a new stake in Nordson in the second quarter valued at $4,085,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Nordson in the second quarter valued at $3,766,000. 72.11% of the stock is currently owned by institutional investors and hedge funds.
Key Headlines Impacting Nordson
Here are the key news stories impacting Nordson this week:
- Positive Sentiment: Strong Q3 beat and broad-based growth: Nordson reported adjusted earnings of $3.25 per share, above the $3.09 consensus and up from $2.73 a year earlier. Revenue reached $817.7 million, exceeding estimates of $779.5 million and increasing 10.3% year over year. Record sales across all segments, stronger orders and broad organic growth supported the results. NDSN Q3 Earnings Beat Estimates on Broad Organic Growth
- Positive Sentiment: Higher fiscal 2026 outlook: Management raised its outlook for the third time, forecasting fiscal 2026 sales of $3.035 billion to $3.075 billion and adjusted EPS of $11.80 to $12.00. Backlog reportedly increased 35%, reinforcing expectations for continued demand and earnings momentum. Nordson Forecasts Fiscal 2026 Sales and EPS
- Positive Sentiment: Analyst price-target increases: Oppenheimer raised its target from $335 to $370 and upgraded its view to “outperform.” Robert W. Baird lifted its target from $328 to $351 while maintaining a “neutral” rating. DA Davidson reaffirmed its “buy” rating with a $345 target. Analysts Boost Forecasts on Nordson
- Neutral Sentiment: New medical product: Nordson MEDICAL introduced its Divert ULTRA line of ultra-high-pressure stopcocks for demanding medical applications. The launch expands the product portfolio but was not accompanied by a specific financial impact. Nordson MEDICAL Introduces Divert ULTRA
- Negative Sentiment: Insider selling and valuation: Reported insider activity showed 46 sales and no purchases over the past six months, including sizable sales by senior executives. After the rally, Nordson trades at roughly 33.6 times earnings, leaving the stock vulnerable to profit-taking if growth or guidance momentum slows.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Nordson
Nordson Price Performance
Shares of NASDAQ NDSN opened at $332.24 on Monday. Nordson Corporation has a twelve month low of $220.06 and a twelve month high of $338.55. The firm has a fifty day simple moving average of $298.83 and a 200 day simple moving average of $287.14. The company has a market capitalization of $18.51 billion, a PE ratio of 33.59, a P/E/G ratio of 2.17 and a beta of 0.96. The company has a quick ratio of 1.18, a current ratio of 1.82 and a debt-to-equity ratio of 0.47.
Nordson (NASDAQ:NDSN – Get Free Report) last released its earnings results on Wednesday, August 19th. The industrial products company reported $3.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.09 by $0.16. The business had revenue of $817.67 million for the quarter, compared to analyst estimates of $779.49 million. Nordson had a net margin of 18.63% and a return on equity of 20.49%. Nordson’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.73 earnings per share. Nordson has set its FY 2026 guidance at 11.800-12.000 EPS. On average, sell-side analysts forecast that Nordson Corporation will post 11.8 EPS for the current year.
Nordson Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 6th. Stockholders of record on Thursday, June 18th were paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Thursday, June 18th. Nordson’s payout ratio is currently 33.16%.
About Nordson
Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company’s portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson’s offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.
Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.
See Also
- Five stocks we like better than Nordson
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding NDSN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nordson Corporation (NASDAQ:NDSN – Free Report).
Receive News & Ratings for Nordson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nordson and related companies with MarketBeat.com's FREE daily email newsletter.
